Armistice Capital »

Accelerate Diagnostics Inc - US shares owned by Armistice Capital

Quarter-by-quarter ownership of Accelerate Diagnostics Inc - US (AXDX) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Accelerate Diagnostics Inc - US

Tip: Access up to 7 years of quarterly data

All positions including Accelerate Diagnostics Inc - US held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Accelerate Diagnostics Inc - US by Armistice Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.9M 1.6M 1.17
2024-03-31 $1.8M 1.8M 0.99

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Ptc Therapeutics I (PTCT)
Cytokinetics Com New (CYTK)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Immunovant (IMVT)
Agios Pharmaceuticals (AGIO)
Argenx Se Sponsored Adr (ARGX)
Novo-nordisk A S Adr (NVO)
Sanofi Sponsored Adr (SNY)
Alkermes SHS (ALKS)
Medtronic SHS (MDT)
Aurinia Pharmaceuticals (AUPH)

View all positions for Armistice Capital

Top funds holding Accelerate Diagnostics Inc - US

Armistice Capital
Griffin Asset Management
Vanguard Group
Geode Capital Management
Spears Abacus Advisors
TCI Wealth Advisors
BlackRock
Cladis Investment Advisory
Belpointe Asset Management
State Street Corporation
Ironwood Wealth Management
Susquehanna International
Millennium Management
Group One Trading
Hanson McClain Advisors

View all funds holding Accelerate Diagnostics Inc - US